629-A A safety and feasibility study of the oral live biotherapeutic MRx0518 with hypofractionated preoperative radiation for resectable pancreatic cancer

• Shubham Pant,
• Cullen Taniguchi,
• Ethan Ludmir,
• Vincent Bernard,
• Sonal Noticewala,
• Eric Perez Perez,
• Ching Wei Tzeng

Affiliations

Shubham Pant

MD Anderson Cancer Center, Houston, TX, USA

Cullen Taniguchi

MD Anderson Cancer Center, Houston, TX, USA

Ethan Ludmir

MD Anderson Cancer Center, Houston, TX, USA

Vincent Bernard

MD Anderson Cancer Center, Houston, TX, USA

Sonal Noticewala

MD Anderson Cancer Center, Houston, TX, USA

Eric Perez Perez

MD Anderson Cancer Center, Houston, TX, USA

Ching Wei Tzeng

MD Anderson Cancer Center, Houston, TX, USA